TrialClinical pharmacology and therapeutics2020

Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product.

Martin Vanderlaan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.